Founded with a mission to revolutionize consumer packaged goods (CPG) through advanced proprietary technologies, Day Three Labs focuses on pharmaceutical-grade cannabinoid infusion. Their core vision is to enhance the predictability and precision of infused product experiences, offering up to five times greater bioavailability compared to traditional methods. The company’s portfolio includes patented technologies that ensure precise doses of cannabinoids and terpenes, tailored to deliver consistent and sophisticated results.

Day Three Labs has attracted notable investors and industry experts who support its innovative approach to cannabinoid infusion. The company’s key achievements include the development of data-backed technologies that significantly improve the efficacy and consistency of infused products. By setting new standards in the CPG market, Day Three Labs has made a substantial impact on how cannabinoid products are perceived and utilized, driving forward the future of cannabis technology.